AUG 18, 2026 · JOURNAL ARTICLE
Effect of BMI on efficacy of androgen receptor pathway inhibitors in patients with metastatic hormone-sensitive prostate cancer
Journal of Oncology Pharmacy Practice
Retrospective cohort study of 330 patients reporting an obesity paradox in mHSPC; confirms known associations but BMI did not retain independent significance in multivariate analysis, limiting practice implications.
Important Confirmatory EvidenceDeniz TuralProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Reported
Sample size330
Median follow-up duration47 months
Median rPFS (entire cohort)34 months